Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors

Written by

in

이전에 소개한 논문에서 추가를 해야할 것인가..

뭔 이 사람들은 계속 발표를 하는지…

2013/04/16 – [공부해 봅시다/Pathology] – Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors

Reference: Leighl, N.B., et al., Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Guideline. J Clin Oncol, 2014.

Comments

Leave a Reply

More posts